Genmab to Submit Biologics License Application to U.S. Food

Company Announcement COPENHAGEN, Denmark; June 30, 2022 – Genmab A/S (Nasdaq: GMAB) today announced its intent to submit a biologics license application...

Related Keywords

Copenhagen , Køavn , Denmark , Japan , Tokyo , New Jersey , United States , Netherlands , Austria , Vienna , Wien , Kalvebod Brygge , Marisol Peron , Andrew Carlsen , Macrophage Propertiesj Immunol , Twitter , Drug Administration , Exchange Commission , Hodgkin Lymphoma Research Foundation , Meeting Of The European Hematology Association , Development Of Novel Anti , Corporate Affairs , Diffuse Large Lymphoma Research Foundation , Company Announcement , Presidential Symposium , Annual Meeting , European Hematology Association , Chief Executive Officer , Largeb Cell Lymphoma , Media Contact , Senior Vice President , Investor Relations , Vice President , Media Release , Annual Report , Y Shaped Genmab , Research Foundation , Hodgkin Lymphoma , Rev Oncol , Clinically Utilized , Directed Antibodies , Macrophage Properties , Novel Anti Cd , Cell Surface , Cancer Sci , Copenhagen Stock Exchange Gen , Genmaba S , Bispecific Antibody , Lymphoma , Biologics License Application ,